Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Arch Virol

Retrieve available abstracts of 58 articles:
HTML format
Text format



Single Articles


    November 2017
  1. YANG S, Xing H, Feng S, Ju W, et al
    Prevalence of NS5B resistance-associated variants in treatment-naive Asian patients with chronic hepatitis C.
    Arch Virol. 2017 Nov 15. doi: 10.1007/s00705-017-3640.
    PubMed     Text format     Abstract available


  2. GORI A, Gheorgita S, Spinu C, Pinzaru I, et al
    Hepatitis B, C and D virus genotypes detected in HBsAg- or anti-HCV-positive people from the Republic of Moldova.
    Arch Virol. 2017 Nov 8. doi: 10.1007/s00705-017-3632.
    PubMed     Text format     Abstract available


  3. DE MIRANDA BKB, de Sa KSG, da Silva ANR, Feitosa RNM, et al
    GBV-C/HIV-1 coinfection is associated with low HIV-1 viral load and high CD4+ T lymphocyte count.
    Arch Virol. 2017;162:3431-3438.
    PubMed     Text format     Abstract available


    October 2017
  4. BADFAR G, Shohani M, Nasirkandy MP, Mansouri A, et al
    Epidemiology of hepatitis B in pregnant Iranian women: a systematic review and meta-analysis.
    Arch Virol. 2017 Oct 23. doi: 10.1007/s00705-017-3551.
    PubMed     Text format     Abstract available


  5. NGUYEN LT, Van Nguyen D, Carr MJ, Hall WW, et al
    Association of interferon lambda polymorphisms with elevated baseline viral loads in chronic hepatitis C virus genotype 6 infection.
    Arch Virol. 2017 Oct 11. doi: 10.1007/s00705-017-3583.
    PubMed     Text format     Abstract available


  6. ABD-ELSALAM S, Sharaf-Eldin M, Soliman S, Elfert A, et al
    Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice.
    Arch Virol. 2017 Oct 5. doi: 10.1007/s00705-017-3573.
    PubMed     Text format     Abstract available


    September 2017
  7. FERREIRA AC, Gomes-Gouvea MS, Lisboa-Neto G, Mendes-Correa MCJ, et al
    Serological and molecular markers of hepatitis E virus infection in HIV-infected patients in Brazil.
    Arch Virol. 2017 Sep 30. doi: 10.1007/s00705-017-3562.
    PubMed     Text format     Abstract available


  8. RAMIREZ-SOTO MC, Bracho MA, Gonzalez-Candelas F, Huichi-Atamari M, et al
    Genotypes and subgenotypes of hepatitis B virus circulating in an endemic area in Peru.
    Arch Virol. 2017 Sep 25. doi: 10.1007/s00705-017-3557.
    PubMed     Text format     Abstract available


  9. PONDE RAA
    The serological markers of acute infection with hepatitis A, B, C, D, E and G viruses revisited.
    Arch Virol. 2017 Sep 7. doi: 10.1007/s00705-017-3538.
    PubMed     Text format     Abstract available


    July 2017
  10. YOUSSEF SS, Hamdy NM
    SOCS1 and pattern recognition receptors: TLR9 and RIG-I; novel haplotype associations in Egyptian fibrotic/cirrhotic patients with HCV genotype 4.
    Arch Virol. 2017 Jul 31. doi: 10.1007/s00705-017-3498.
    PubMed     Text format     Abstract available


  11. DAUD M, Rana MA, Husnain T, Ijaz B, et al
    Modulation of Wnt signaling pathway by hepatitis B virus.
    Arch Virol. 2017 Jul 6. doi: 10.1007/s00705-017-3462.
    PubMed     Text format     Abstract available


    June 2017
  12. ELHELW DS, Riad SE, Shawer H, El-Ekiaby N, et al
    Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of Occludin.
    Arch Virol. 2017 Jun 22. doi: 10.1007/s00705-017-3449.
    PubMed     Text format     Abstract available


  13. QU C, Xu L, Yin Y, Peppelenbosch MP, et al
    Nucleoside analogue 2'-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin.
    Arch Virol. 2017 Jun 16. doi: 10.1007/s00705-017-3444.
    PubMed     Text format     Abstract available


  14. LI S, Xie M, Li W, Peng Q, et al
    Prevalence of S gene mutations within the major hydrophilic region of hepatitis B virus in patients in Dongguan, southern China.
    Arch Virol. 2017 Jun 9. doi: 10.1007/s00705-017-3437.
    PubMed     Text format     Abstract available


    May 2017
  15. CATTOIR L, Van Hoecke F, Van Maerken T, Nys E, et al
    Hepatitis E virus serology and PCR: does the methodology matter?
    Arch Virol. 2017 May 18. doi: 10.1007/s00705-017-3395.
    PubMed     Text format     Abstract available


    April 2017
  16. RODRIGUEZ LAY LLA, Bello Corredor M, Montalvo Villalba MC, Chibas Ojeda AG, et al
    Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers.
    Arch Virol. 2017 Apr 24. doi: 10.1007/s00705-017-3365.
    PubMed     Text format     Abstract available


  17. MORSICA G, Andolina A, Merli M, Messina E, et al
    NS3 protease resistance-associated substitutions in liver tissue and plasma samples from patients infected by hepatitis C virus genotype 1A or 1B.
    Arch Virol. 2017 Apr 18. doi: 10.1007/s00705-017-3341.
    PubMed     Text format     Abstract available


    March 2017
  18. HAMZA H, Abd-Elshafy DN, Fayed SA, Bahgat MM, et al
    Detection and characterization of hepatitis A virus circulating in Egypt.
    Arch Virol. 2017 Mar 16. doi: 10.1007/s00705-017-3294.
    PubMed     Text format     Abstract available


  19. CASTELAIN S, Descamps V, Brochot E, Helle F, et al
    High association of T1858-G1896 precore mutations with impaired base pairing and high hepatitis B virus DNA levels in HBeAg-negative chronically infected patients.
    Arch Virol. 2017 Mar 13. doi: 10.1007/s00705-017-3312.
    PubMed     Text format     Abstract available


    February 2017
  20. BENSALEM A, Selmani K, Narjes H, Bencherifa N, et al
    Widespread geographical disparities in chronic hepatitis B virus infection in Algeria.
    Arch Virol. 2017 Feb 24. doi: 10.1007/s00705-017-3284.
    PubMed     Text format     Abstract available


  21. MUGOSA B, Cella E, Lai A, Lo Presti A, et al
    Hepatitis C virus genotype 3A in a population of injecting drug users in Montenegro: Bayesian and evolutionary analysis.
    Arch Virol. 2017 Feb 13. doi: 10.1007/s00705-017-3224.
    PubMed     Text format     Abstract available


  22. SPITZ N, Moreira AS, Mello FC, Franz HC, et al
    Complete genome sequence of a hepatitis B virus isolate of genotype D2, subtype adrq+, from Brazil.
    Arch Virol. 2017 Feb 8. doi: 10.1007/s00705-017-3269.
    PubMed     Text format     Abstract available


  23. NICZYPORUK JS
    Molecular characterisation of fowl adenovirus type 7 isolated from poultry associated with inclusion body hepatitis in Poland.
    Arch Virol. 2017 Feb 3. doi: 10.1007/s00705-017-3240.
    PubMed     Text format     Abstract available


    November 2016
  24. PISANO MB, Balderramo D, Wassaf MM, Lotto M, et al
    Hepatitis E virus infection in patients on dialysis and in solid organ transplant recipients in Argentina: exploring associated risk factors.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  25. PURDY MA, Sue A
    The effect of phylogenetic signal reduction on genotyping of hepatitis E viruses of the species Orthohepevirus A.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  26. SANTANA LC, Mantovani NP, Ferreira MC, Arnold R, et al
    Identification of a new hepatitis B virus recombinant D2/D3 in the city of Sao Paulo, Brazil.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  27. ZHANG Z, Zhang Y, Xu N, Huang C, et al
    High risk of occult hepatitis B virus infection in leukemia patients from China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  28. ANDRADE AP, Pacheco SD, Silva FQ, Pinheiro LM, et al
    Characterization of hepatitis B virus infection in illicit drug users in the Marajo Archipelago, northern Brazil.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  29. SEDIGHIMEHR P, Irani S, Sakhaee F, Vaziri F, et al
    IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  30. NOBLE CF, Malta F, Lisboa-Neto G, Gomes-Gouvea MS, et al
    Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  31. HELALY GF, Elsheredy AG, El Basset Mousa AA, Ahmed HK, et al
    Seronegative and occult hepatitis C virus infections in patients with hematological disorders.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  32. ZAGHLOUL H, El Morsi AA, Soweha HE, Elsayed A, et al
    A simple real-time polymerase chain reaction assay using SYBR Green for hepatitis C virus genotyping.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  33. AGHASADEGHI MR, Velayati AA, Mamishi S, Nabavi M, et al
    Low prevalence of hepatitis B vaccine escape mutants among individuals born after the initiation of a nationwide vaccination program in Iran.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  34. TAKAHASHI M, Kobayashi T, Tanggis, Jirintai S, et al
    Production of monoclonal antibodies against the ORF3 protein of rat hepatitis E virus (HEV) and demonstration of the incorporation of the ORF3 protein into enveloped rat HEV particles.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  35. MEHTA M, Hetta HF, Abdel-Hameed EA, Rouster SD, et al
    Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  36. JONES LR, Sede M, Manrique JM, Quarleri J, et al
    Hepatitis B virus resistance substitutions: long-term analysis by next-generation sequencing.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  37. GOLSAZ-SHIRAZI F, Mohammadi H, Amiri MM, Khoshnoodi J, et al
    Localization of immunodominant epitopes within the "a" determinant of hepatitis B surface antigen using monoclonal antibodies.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  38. DE CONTO F, Medici MC, Ferraglia F, Pinardi F, et al
    Temporal dynamics of hepatitis C genotypes in a five-year hospital-based surveillance in Northern Italy.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  39. DI PROFIO F, Melegari I, Sarchese V, Robetto S, et al
    Detection and genetic characterization of hepatitis E virus (HEV) genotype 3 subtype c in wild boars in Italy.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  40. PISANO MB, Blanco S, Carrizo H, Re VE, et al
    Hepatitis B virus infection in blood donors in Argentina: prevalence of infection, genotype distribution and frequency of occult HBV infection.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  41. ABDELRAHEEM WM, Hassuna NA, Abuloyoun SM, Abdel Ghany HM, et al
    Interleukin-10.rs1800896 and Interleukin-18.rs1946518 gene polymorphisms could not predict the outcome of hepatitis C virus infection in Egyptian patients treated with pegylated interferon plus ribavirin.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  42. EL-BENDARY M, Hawas S, El-Hammady D, Al-Hadidy AM, et al
    Profile of expression of certain markers of apoptosis in chronic hepatitis C and hepatitis B patients in an Egyptian population.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  43. CHOI JW, Jung JY, Lee JI, Lee KK, et al
    Molecular characteristics of a novel strain of canine minute virus associated with hepatitis in a dog.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  44. GASPARETO KV, Ribeiro RM, de Mello Malta F, Gomes-Gouvea MS, et al
    HCV inter-subtype 1a/1b recombinant detected by complete-genome next-generation sequencing.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  45. KONG L, Li S, Yu X, Fang X, et al
    Hepatitis C virus and its protein NS4B activate the cancer-related STAT3 pathway via the endoplasmic reticulum overload response.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  46. BASTANI MN, Bokharaei-Salim F, Keyvani H, Esghaei M, et al
    Prevalence of occult hepatitis C virus infection in Iranian patients with beta thalassemia major.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  47. GONG T, Zhao X, Luo Y, Hong Y, et al
    Distribution of hepatitis C virus genotypes in volunteer blood donors from Chengdu, China.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  48. DE SEIXAS SANTOS NASTRI AC, de Mello Malta F, Diniz MA, Yoshino A, et al
    Association of IFNL3 and IFNL4 polymorphisms with hepatitis C virus infection in a population from southeastern Brazil.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  49. ZHANG Y, Cheng J, Liu C
    The unique role of the hepatitis virus B X protein on HEK 293 cell morphology and cellular change.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  50. DI BARTOLO I, De Sabato L, Marata A, Martinelli N, et al
    Serological survey of hepatitis E virus infection in farmed and pet rabbits in Italy.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  51. JOVANOVIC-CUPIC S, Glisic S, Stanojevic M, Nozic D, et al
    The influence of host factors and sequence variability of the p7 region on the response to pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b in patients from Serbia.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


  52. GALANI BR, Sahuc ME, Sass G, Njayou FN, et al
    Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro.
    Arch Virol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  53. SEGGEWISS N, Kruse HV, Weilandt R, Domsgen E, et al
    Cellular localization and effects of ectopically expressed hepatitis A virus proteins 2B, 2C, 3A and their intermediates 2BC, 3AB and 3ABC.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  54. IKEZAKI H, Furusyo N, Hiramine S, Ura K, et al
    Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional study.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  55. LI WY, Ren JH, Tao NN, Ran LK, et al
    The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  56. HERNANDEZ S, Jimenez G, Alarcon V, Prieto C, et al
    Replication of a chronic hepatitis B virus genotype F1b construct.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


  57. LIN SL, Cong RC, Zhang RH, Chen JH, et al
    Circulation and in vivo distribution of duck hepatitis A virus types 1 and 3 in infected ducklings.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  58. HADIJI-ABBES N, Mihoubi W, Martin M, Karakasyan-Dia C, et al
    Characterization of C69R variant HBsAg: effect on binding to anti-HBs and the structure of virus-like particles.
    Arch Virol. 2015;160:2427-33.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: